25 Jan Section 21 Access to Unregistered Medicines – IVERMECTIN CONTROLLED COMPASSIONATE USE PROGRAMME
Posted at 13:18h
in
Given that there is currently no credible evidence to support a therapeutic role for Ivermectin in COVID-19, SAHPRA has decided to terminate the Programme with immediate effect.
Archive
Ivermectin Controlled Compassionate Use ProgrammeDate uploaded
2022 May
Download latest version
Version:
2
Date Updated:
19/05/2022
File Type:
www
Category:
Communication to industry, Guideline